Potassium Bromide in the Treatment of Pediatric Refractory Epilepsy
Kazuo Kodama1, Taku Omata1, Yoshimi Watanabe1
11 Division of Child Neurology, Chiba Children's Hospital, Chiba, Japan.
Insights
Potassium bromide (KBr) showed moderate to excellent efficacy in 59.1% of pediatric refractory epilepsy cases. KBr was particularly effective for tonic and generalized seizures, with manageable side effects.
Area of Science:
- Neurology
- Pediatric Neurology
- Epileptology
Background:
- Pediatric refractory epilepsy presents significant treatment challenges.
- Exploring alternative or adjunctive therapies is crucial for improving seizure control in children.
- Potassium bromide (KBr) has historical use but requires updated efficacy and tolerability data.
Purpose of the Study:
- To evaluate the efficacy and tolerability of potassium bromide (KBr) as a treatment for pediatric refractory epilepsy.
- To identify specific seizure types that respond best to KBr therapy.
- To assess the safety profile and adverse effects associated with KBr use in children.
Main Methods:
- Retrospective review of 42 pediatric patients treated with KBr between 2008 and 2016.
- Analysis of seizure frequency reduction, effective dosage, and adverse events.
- Stratification of efficacy based on epilepsy type and seizure semiology.
Main Results:
- KBr demonstrated efficacy in 59.1% of patients, with 7.1% achieving seizure-free status and 50.0% experiencing >50% seizure reduction.
- The drug was particularly effective for tonic seizures (72.2%), generalized tonic-clonic seizures (66.6%), and secondary generalized seizures (75.0%).
- Adverse effects, including drowsiness and rashes, were reported in 31.0% of patients.
Conclusions:
- Potassium bromide (KBr) is a viable option for pediatric refractory epilepsy, especially for specific seizure types.
- Its efficacy in controlling tonic, generalized tonic-clonic, and secondary generalized seizures warrants consideration.
- While adverse effects are present, they appear manageable, supporting KBr's role in refractory epilepsy management.
Objective:
We evaluated potassium bromide's (KBr's) efficacy and tolerability for pediatric refractory epilepsy.
Methods:
We retrospectively reviewed the records of 42 patients treated with KBr in our hospital between 2008 and 2016 (age: 4 months to 19 years; mean: 6.2 years). Thirteen of them had 2 seizure types. The treatment durations ranged from 1 month to 6 years (mean: 15.0 months).
Results:
KBr had an excellent effect (seizure-free status) in 3 patients (7.1%), a moderate effect (>50% reduction in seizure frequency from the pretreatment baseline) in 21 patients (50.0%), and no effect (<50% reduction in seizure frequency from the pretreatment baseline) in 18 patients (42.9%). The effective daily doses ranged from 20 to 80 mg/kg (mean: 50.0 mg/kg). KBr was effective in 59.1% patients with generalized epilepsy (n = 22), 55.6% patients with focal epilepsy (n = 18), and both patients with Dravet syndrome. An excellent or moderate effect was found in 72.2% patients with tonic seizures (n = 18), 66.6% patients with generalized tonic-clonic seizures (n = 6), 75.0% patients with secondary generalized seizures (n = 4), 46.2% patients with focal seizures (n = 13), and 20% patients with infantile spasms (n = 10) but no patients with myoclonic seizures (n = 2). Adverse effects including drowsiness, excitement, and rashes were reported in 13 patients (31.0%).
Conclusions:
These findings suggest that KBr is particularly effective for tonic seizures, generalized tonic-clonic seizures, and secondary generalized seizures. Although the adverse effects need further attention, KBr should be considered for pediatric refractory epilepsy.
More Related Videos
Related Concept Videos
01:26Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
01:24Roles of Electrolytes: Sodium and Potassium
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
02:21Oxidation of Alkenes: Syn Dihydroxylation with Potassium Permanganate